6533b870fe1ef96bd12cfd92

RESEARCH PRODUCT

Robust Automated Assessment of Human Blastocyst Quality using Deep Learning

Jonas MalmstenZev RosenwaksEhsan KazemiIman HajirasoulihaOlivier ElementoPegah KhosraviNikica ZaninovicMarcos MeseguerM. ToschiCristina HickmanQiansheng Zhan

subject

animal structuresComputer sciencemedia_common.quotation_subjectmedicine.medical_treatmentMachine learningcomputer.software_genre03 medical and health sciences0302 clinical medicinemedicineQuality (business)Blastocyst030304 developmental biologymedia_common0303 health sciencesPregnancy030219 obstetrics & reproductive medicineIn vitro fertilisationbusiness.industryDeep learningEmbryomedicine.diseasemedicine.anatomical_structureembryonic structuresArtificial intelligencebusinessLive birthcomputerEmbryo quality

description

AbstractMorphology assessment has become the standard method for evaluation of embryo quality and selecting human blastocysts for transfer inin vitro fertilization(IVF). This process is highly subjective for some embryos and thus prone to human bias. As a result, morphological assessment results may vary extensively between embryologists and in some cases may fail to accurately predict embryo implantation and live birth potential. Here we postulated that an artificial intelligence (AI) approach trained on thousands of embryos can reliably predict embryo quality without human intervention.To test this hypothesis, we implemented an AI approach based on deep neural networks (DNNs). Our approach called STORK accurately predicts the morphological quality of blastocysts based on raw digital images of embryos with 98% accuracy. These results indicate that a DNN can automatically and accurately grade embryos based on raw images. Using clinical data for 2,182 embryos, we then created a decision tree that integrates clinical parameters such as embryo quality and patient age to identify scenarios associated with increased or decreased pregnancy chance. This IVF data-driven analysis shows that the chance of pregnancy varies from 13.8% to 66.3%.In conclusion, our AI-driven approach provides a novel way to assess embryo quality and uncovers new, potentially personalized strategies to select embryos with an improved likelihood of pregnancy outcome.

https://doi.org/10.1101/394882